Ambit Health Ventures

Ambit Health Ventures is a healthcare venture capital firm that focuses on investments in early-stage digital health and MedTech firms. It aims to improve healthcare through their portfolio companies’ innovation while achieving financial gain for its investors.

Zach Praw

Investment Analyst

3 past transactions

Wavely Diagnostics

Seed Round in 2022
Wavely Diagnostics is pioneering the future of remote digital diagnostics and enabling telehealth growth by leveraging smartphone technology to address pediatric care.

Smartlens

Seed Round in 2021
Smartlens is a clinical-stage Med Tech company with a portfolio of technologies to treat and diagnose Glaucoma - a chronic eye disease and the leading cause of irreversible blindness. The Company is running clinical trials with its novel eye pressure (IOP) monitoring contact lens (miLens) that will help improve clinical outcomes in Glaucoma. The disease affects hundreds of millions around the globe; even in developed countries more than 50% of the patients are currently undiagnosed, and more than 38% are going blind despite being treated. The need for monitoring eye pressure outside the clinic has been defined as an urgent need by scientific, medical, and industry leaders in ophthalmology that will help improve clinical outcomes. Smartlens’ flagship product miLens is a non-invasive and convenient way of monitoring eye pressure for anyone anywhere at any time. It will help improve early diagnosis, enable personalized treatments, and disease monitoring thus reducing the prevalence of blindness, treatment costs, and its huge burden on lives and economies. miLens is utilizing a novel, electronics-free sensor technology that is fully owned by Smartlens, Inc. and protected by its portfolio of issued and pending patents covering more than 40 countries. The Company's novel technology is also being studied at Stanford University Labs for monitoring (ICP) which is associated with certain neurological disorders, and cancers. Smartlens also owns a non-invasive drug delivery technology that monitors the IOP and releases the right medication at the right time which will help improve efficacy, patient compliance and reduce the side effects. Smartlens is the Winner of the 2021 "Outstanding Innovation in Medical Technology and Life Sciences" of High-Tech Awards by Octane. The Company has been invited to various national and international conferences, published its studies, listed among the Top 10 MedTech Startups, and featured in ABC7, Fortune, BBC, and Nature Medicine.

Bone Health Technologies

Venture Round in 2021
Bone Health Technologies is a Redwood City-based health-tech company developing innovative, non-invasive, and science-backed solutions for people with low bone density. Its flagship product, Osteoboost, is an FDA-cleared wearable medical device clinically proven to significantly slow the loss of bone density and bone strength through patented precision vibration therapy in postmenopausal women with osteopenia. Inspired by NASA-funded research and driven by science and a commitment to improving health outcomes, Osteoboost is poised to become the new standard of care – offering a convenient, non-pharmacological, pain-free treatment to the nearly 64 million Americans at risk of osteoporotic fractures.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.